Stockreport

Palisade Bio Announces Participation in Two Upcoming Investor Conferences

Palisade Bio, Inc.  (PALI) 
PDF Carlsbad, CA, March 02, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing [Read more]